Renal Cell Carcinoma: Developing Drugs and Biologics for Adjuvant Treatment

Draft Guidance for Industry: Renal Cell Carcinoma: Developing Drugs and Biologics for Adjuvant Treatment

Source: FDA Center for Drug Evaluation and Research - What's New - October 1, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

More News: Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Kidney Cancer | Renal Cell Carcinoma